Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery

Journal of Cardiac Surgery
Kristian B FilionMark J Eisenberg

Abstract

Previous studies have demonstrated that cardiac medical therapy is associated with improved clinical outcomes in noncardiac surgery. However, the use of these agents among patients undergoing coronary artery bypass graft (CABG) remains poorly understood. We described the in-hospital medication use among 2,389 consecutive patients who underwent CABG at three North American hospitals. Demographic, clinical, and medication use information was extracted from resource and cost accounting systems at each hospital. We examined use of aspirin, angiotensin-converting-enzyme (ACE) inhibitors, beta blockers, and statins during the following seven in-hospital periods: admission, presurgery, the day before surgery, the day of surgery, the day after surgery, postsurgery, and discharge. Medication use throughout hospitalization was low among patients undergoing CABG. Use of ACE inhibitors and statins on the day of surgery was <10%, while aspirin and beta blocker use on the day of surgery was 43.0% and 42.9%, respectively. The use of cardiac medical therapy at hospital discharge was also low (ACE inhibitors: 23.0%; aspirin: 74.9%; beta blockers: 58.9%; and statins: 28.2%). The use of cardiac medical therapy at discharge appeared to increase ov...Continue Reading

References

Jan 1, 1992·International Anesthesiology Clinics·L A Fleisher
Jun 1, 1997·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·I M AliV Clark
May 13, 1998·Circulation·N J Brown, D E Vaughan
Jun 27, 1998·Cardiovascular Drugs and Therapy·W W Parmley
Jun 25, 1999·BMJ : British Medical Journal·N FreemantleJ Harrison
Jan 15, 2000·Journal of the American College of Cardiology·C J VaughanC T Basson
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Nov 14, 2000·The American Journal of Cardiology·M I DotaniC M Gibson
Jan 13, 2001·The Annals of Thoracic Surgery·L J DaceyUNKNOWN Northern New England Cardiovascular Disease Study Group
Mar 21, 2002·JAMA : the Journal of the American Medical Association·Andrew D Auerbach, Lee Goldman
Mar 21, 2002·JAMA : the Journal of the American Medical Association·Andrew D Auerbach, Lee Goldman
May 1, 2002·JAMA : the Journal of the American Medical Association·T Bruce FergusonUNKNOWN Society of Thoracic Surgeons National Adult Cardiac Surgery Database
Oct 25, 2002·The New England Journal of Medicine·Dennis T Mangano, UNKNOWN Multicenter Study of Perioperative Ischemia Research Group
Jul 5, 2003·The Annals of Thoracic Surgery·Arun K SrinivasanWalid C Dihmis
Nov 1, 2003·Thrombosis Research·J R Vane, R M Botting
Jan 18, 2005·Journal of the American College of Cardiology·Karen OkrainecMark J Eisenberg
Jul 13, 2005·Archives of Internal Medicine·Mark J EisenbergLouise Pilote
Jul 22, 2005·The New England Journal of Medicine·Scott C WilliamsJerod M Loeb

❮ Previous
Next ❯

Citations

Jan 23, 2016·The Annals of Thoracic Surgery·Amr F BarakatIslam Y Elgendy
Aug 12, 2009·The Medical Clinics of North America·Alec D WeisbergCharles D Collard
Nov 28, 2009·Anesthesiology Clinics·Alec D WeisbergCharles D Collard
Nov 23, 2019·Journal of the American Heart Association·Harold L Lazar
May 31, 2013·Journal of Cardiopulmonary Rehabilitation and Prevention·Randal J ThomasRay Gibbons

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.